Literature DB >> 7192393

Maximum oxygen consumption in dogs during muscular exercise and cold exposure.

A Lucas, A Therminarias, M Tanche.   

Abstract

Maximum oxygen consumption for a short exhaustive work (Ex VO2 max) and for a severe cold stress (C VO2 max) were investigated in 8 dogs. Heart rate, plasma catecholamines and substrate concentrations were measured under both conditions. Mean C VO2 max was lower than mean Ex VO2 max. Heart rate and plasma lactate were also lower during cold exposure than during exercise. Average plasma epinephrine concentrations were not significantly different and average plasma norepinephrine concentrations were similar under C VO2 max and Ex VO2 max conditions. A positive correlation was found between plasma lactate and epinephrine concentrations measured under both conditions. It may be assumed that maximum oxygen consumption during muscular exercise is higher than during shivering thermogenesis. This difference does not seem to be due to differences in the involvement of the sympathico-adreno-medullary system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192393     DOI: 10.1007/bf00582633

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  32 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Metabolic alterations during chronic exposure to cold.

Authors:  J S HART
Journal:  Fed Proc       Date:  1958-12

3.  Effect of cold and epinephrine on glucose kinetics in dogs.

Authors:  J Forichon; M J Jomain; G Dallevet; Y Minaire
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-08

4.  Adaptations in man's adrenal function in response to acute cold stress.

Authors:  J E Wilkerson; P B Raven; N W Bolduan; S M Horvath
Journal:  J Appl Physiol       Date:  1974-02       Impact factor: 3.531

5.  Comparison of carbohydrate utilization in running and shivering dogs.

Authors:  Y Minaire; A Pernod; J C Vincent-Falquet; M Mottaz
Journal:  Horm Metab Res       Date:  1973-03       Impact factor: 2.936

6.  Swimming compared to cold for eliciting maximal oxygen uptake in mice.

Authors:  R M Glaser; H S Weiss
Journal:  Proc Soc Exp Biol Med       Date:  1973-12

7.  Lactate turnover and oxidation in normal and adrenal-demedullated dogs during cold exposure.

Authors:  Y Minaire; A Pernod; M J Jomain; M Mottaz
Journal:  Can J Physiol Pharmacol       Date:  1971-12       Impact factor: 2.273

8.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

Review 9.  Neuroendocrine aspects of thermoregulation.

Authors:  C C Gale
Journal:  Annu Rev Physiol       Date:  1973       Impact factor: 19.318

10.  Catecholamines in dogs during cold adaptation by repeated immersions.

Authors:  A Therminarias; M F Chirpaz; A Lucas; M Tanche
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-04
View more
  4 in total

1.  Plasma renin activity and plasma catecholamines in intact and splenectomized running and swimming beagle dogs.

Authors:  J A Joles; J M den Hertog; G H Huisman; W J Kraan; F W van Schaik; A C Schrikker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

2.  Maximum oxygen consumption and catecholamines in thyroidectomized dogs.

Authors:  A Therminarias; A Lucas
Journal:  Pflugers Arch       Date:  1982-11-11       Impact factor: 3.657

3.  Effect of cold ambient temperature on glucose and alanine turnover in dogs.

Authors:  Y Minaire; M Cagnard; A Fréminet; J Forichon; G Dallevet
Journal:  Pflugers Arch       Date:  1982-11-01       Impact factor: 3.657

4.  Influence of cold exposure on blood lactate response during incremental exercise.

Authors:  A Therminarias; P Flore; M F Oddou-Chirpaz; E Pellerei; A Quirion
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.